Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OMERACT Core Domain Set Selection for Calcium Pyrophosphate Deposition (CPPD): Exploring Patient and Stakeholder Perspectives on Outcome Domains

NCT04176003 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT04176003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04176003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OMERACT Core Domain Set Selection for Calcium Pyrophosphate Deposition (CPPD): Exploring Patient and Stakeholder Perspectives on Outcome Domains
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Completed
Start date
October 8, 2019
Completion date
January 10, 2020
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cppd - calcium pyrophosphate deposition disease